Vimarsana
Biggest News Aggregation in the World

Page 2 - Catherinet Doherty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Catherinet Doherty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Catherinet Doherty Today - Breaking & Trending Today

Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Motley Fool Asset Management LLC - Vimarsana News

Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC trimmed its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,822 shares of the medical research company’s stock after selling 189 shares during the quarter. […]

Source: wkrb13.com
Quest Diagnostics (NYSE:DGX) Releases FY 2024 Earnings Guidance - Vimarsana News

Quest Diagnostics (NYSE:DGX) Releases FY 2024 Earnings Guidance

Quest Diagnostics (NYSE:DGX – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 8.720-8.970 for the period, compared to the consensus EPS estimate of 8.750. The company issued revenue guidance of $9.4 billion-$9.5 billion, compared to the consensus revenue estimate of $9.4 billion. […]

Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Cwm LLC - Vimarsana News

Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Cwm LLC

Cwm LLC increased its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,200 shares of the medical research company’s stock after purchasing an additional 232 shares during the period. […]

Quest Diagnostics (NYSE:DGX) Price Target Raised to $145.00 - Vimarsana News

Quest Diagnostics (NYSE:DGX) Price Target Raised to $145.00

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price boosted by investment analysts at Citigroup from $135.00 to $145.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Citigroup’s target price suggests a potential upside of 5.27% from the company’s previous […]

Source: wkrb13.com
Citigroup Raises Quest Diagnostics (NYSE:DGX) Price Target to $145.00 - Vimarsana News

Citigroup Raises Quest Diagnostics (NYSE:DGX) Price Target to $145.00

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by research analysts at Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the medical research company’s stock. Citigroup’s price target suggests a potential upside of 5.27% from the company’s current […]